Source: Annual Congress 2001 - Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Marchand, B. Etienne-Mastroianni, P. Chanez, D. Lauque, P. Leclerc, J. F. Cordier (Lyon, France). Asthma and chronic idiopathic eosinophilic pneumonia (CIEP): a study of 52 patients. Eur Respir J 2001; 16: Suppl. 31, 140

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003 A clinical study of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 A study on the pulmonary function of patients with chronic eosinophilic pneumonia Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Manifestation of idiopathic chronic eosinophilic pneumonia Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Development of chronic airway obstructive in patients with eosinophilic bronchitis: a prospective follow up study Source: Eur Respir J 2003; 22: Suppl. 45, 423s Year: 2003 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Idiopathic acute and chronic eosinophilic pneumonia Source: Annual Congress 2009 - Update on eosinophilic lung diseases Year: 2009 Clinical implication of interleukin-33 in acute eosinophilic pneumonia compared with chronic eosinophilic pneumonia Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Clinical-pathologic study on small airways in patients with idiopathic interstitial pneumonia Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Fibrosing cases of chronic eosinophilic pneumonia Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Development of asthma in patients with eosinophilic bronchitis: prospective follow up study Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA) Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Causes of chronic cough in patients with interstitial pneumonia Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008 Clinical-radiographic-pathologic diagnosis in idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Fibrosing alveolitis in rheumatoid arthritis (FARA):a survival comparison with idiopathic usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP) Source: Eur Respir J 2003; 22: Suppl. 45, 197s Year: 2003